Clinical Trial Update: Omega 3 Supplementation and Ocular Surface Disease in Glaucoma [NA]

View source ↗

Summary

The clinical trial investigating omega-3 supplementation for ocular surface disease in glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Surface Disease

Drugs mentioned

• Omega-3 supplementation (Omega-3 fatty acids)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Ocular Surface Disease | NA | Status: WITHDRAWN